Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects
Crossref DOI link: https://doi.org/10.1007/s11427-016-5025-6
Published Online: 2016-03-11
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Di, Shengmeng
Li, Zonghai